Intus Healthcare Ltd are a specialist healthcare company providing therapeutic options for proactive people.

We are authorised resellers or distributors for many multi-national corporations including Sunrise Medical Inc., Cardinal Health (NYSE:CAH), Fisher & Paykel (NSX:FPH), Philips Respironics (www.CPAP-Europe.com), Covidien (NYSE:COV) Health Solutions Inc, Weinmann Medical Technology and hold several UK or EU exclusive product licenses. Intus are also the UK distribution partner for SomnoMed Limited (ASX:SOM) manufacturer of a high end mandibular advancement splint used for treating sleep apnoea.

With an extensive portfolio of well developed educational and e-commerce websites, the company collectively attracts over 250,000 unique visitors per year, growing exponentially. We offer one of the largest choices of sleep disordered therapy devices in Western Europe and supply other homecare product solutions for conditions such as cystitis, depression (see the 'Litebook Elite') and sinusitis.

Intus provide private patients a unique in-home screening service for obstructive sleep apnoea / sleep disordered breathing and are well positioned to expand into additional diagnostic services. We have a strong medical advisory board to guide future growth into the EU and combined with our years of experience in healthcare marketing, help thousands of patients annually.

Intus are the UK and Ireland Distribution partners for OvPlex (TM), the world's first commercially available diagnostic for early stage ovarian cancer detection in sympomatic women licensed from HealthLinx (ASX:HTX). Sales are expected to begin in Q4 2009.